Global Patient-Centric Healthcare App Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Report – Segmented By Type, Technology, Operating System, End-User & Region (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa)- Industry Forecast (2024 to 2029)

Updated On: June, 2024
ID: 11855
Pages: 190

Global Patient-Centric Healthcare App Market Size (2024 to 2029)

The global patient-centric healthcare app market size is estimated to be worth USD 49678.02 million by 2029 from USD 1099.17 million in 2024, growing at a CAGR of 35.20% during the forecast period.

Current Scenario of the Patient-Centric Healthcare App Market

Healthcare apps are a rapidly growing technology and service industry. The global coronavirus pandemic (COVID-19) has prompted a shift to remote work in many industries to prevent the spreading of infectious diseases. Patient-centered applications are defined as systems that allow practitioners, patients, and their families (when appropriate) to collaborate to ensure that procedures and decisions respect patients' needs and preferences. These applications span the clinical and non-clinical sectors and include tools for both individual and population health. They cover various communication channels, including web-based systems, portable monitoring tools, and mobile devices.

MARKET DRIVERS

The growing awareness among people regarding healthcare apps and increasing usage of these apps in developing and developed countries are majorly driving the global patient-centric healthcare app market growth.

All healthcare decisions and quality measurements in patient-centered care are driven by an individual's specific health needs and desired health outcomes. The implementation of medical digital technologies has the potential to improve public accessibility and flexibility in healthcare. It includes open information on health, treatment, complications, and recent biomedical research progress. Diagnostic and medical services are becoming more accessible and available, even in low-income countries.  Patient-centered mobile healthcare applications have frequently targeted asthma, diabetes, and chronic obstructive pulmonary disease (COP).Wearable healthcare monitoring device apps are constantly improving, and home healthcare is becoming rising, driving the global patient-centric healthcare app market during the forecast period.The low-cost, high-performance wearable device apps give healthcare professionals an accurate picture of a patient's health in real-time. In addition, remote patient monitoring and telehealth or telemedicine technology are growing in popularity.  Home telehealth applications use telecommunications and videoconferencing technologies to connect a healthcare provider at a clinical site to patients in their homes. According to the CDC, the US has 12,200 home healthcare agencies (2016). During the year, approximately 4.5 million patients received and completed care (2015).

As the global adoption of mobile phones grows, so does the use of healthcare apps.

Consumers can gain access to health information via the Internet. There is an increase in web-based patient education sites that provide access to information about patients' conditions. The number of smartphones in use is growing at a 7% annual rate, with more than 1 million new cell phones entering the market daily. Because smartphone penetration is still below 70% in many developed countries, such as China and India, the smartphone market has enormous potential. China, India, and the United States are the countries with the most smartphone users. The Internet and mobile phones are becoming increasingly popular. Many low- and middle-income countries have been affected. According to the most recent Ericsson data, the number of smartphone subscribers has surpassed 6 billion, accounting for over three-quarters of all mobile telephones currently in use.Additionally, factors such as the growing adoption of mobile healthcare apps across the globe, the rising prevalence of chronic diseases, the growing aging population, and rapidly expanding digitalization in the healthcare industry are further boosting the growth rate of the global patient-centric healthcare app market.  

MARKET RESTRAINTS

However, the market's growth is expected to be hampered by the high cost of transitioning to a patient-centric approach, inadequate training for healthcare professionals, and an insufficient supply-to-demand ratio. In addition, factors such as lower accuracy of healthcare apps, limited reimbursement coverage, slow adoption of patient-centric healthcare apps in developing economies, a lack of technological awareness among the elderly, and uncertainty in government regulations limit the growth of the patient-centric healthcare app market.

REPORT COVERAGE

REPORT METRIC

DETAILS

Market Size Available

2023 to 2029

Base Year

2023

Forecast Period

2024 to 2029

Segments Covered

By Type, Technology, Operating System, End-User & Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Market Leader Profiled

Merck & Co Inc, Koninklijke Philips N V, Medtronic Plc, Allscripts Healthcare Solutions

 

 

KEY PLAYERS IN THE  PATIENT-CENTRIC HEALTHCARE APP MARKET 

A few of the leading companies in the global patient-centric app market profiled in this report are Merck & Co Inc, Koninklijke Philips N V, Medtronic Plc, Allscripts Healthcare Solutions, Inc., Hill-Rom Holdings Inc, International Business Machines Corporation (IBM), Bayer AG, Pfizer Inc., Siemens Healthineers AG, iPatientCare, Inc., Boston Scientific Corporation, and Novartis AG.

DETAILED SEGMENTATION OF THE GLOBAL PATIENT-CENTRIC HEALTHCARE APP MARKET  INCLUDED IN THIS REPORT

This research report on the global patient-centric healthcare app market has been segmented and sub-segmented based on type, technology, operating system, end-user & region.

By Type

  • Wellness Management
    • Fitness Patient-Centric Apps
    • Lifestyle & Stress Patient-Centric Apps
    • Diet & Nutrition Patient-Centric Apps
  • Diseases & Treatment Management
    • Healthcare Providers/Insurance Patient-Centric Apps
    • Medication Reminders & Information Patient-Centric Apps
    • Women’s Health & Pregnancy Patient-Centric Apps
    • Disease-specific patient-centric apps 

By Technology

  • Phone-Based Apps
  • Web-Based Apps
  • Wearable Patient-Centric Apps

By Operating System

  • iOS
  • Android
  • Windows
  • Others

By End User

  • Hospitals
  • Clinics
  • Home Use

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • The Middle East and Africa

Please wait. . . . Your request is being processed

Frequently Asked Questions

What is the current size of the patient-centric healthcare app market?

The global patient-centric healthcare app market is expected to be USD 8134 million in 2023.

Who are the key players in the patient-centric healthcare app market?

Merck & Co Inc, Koninklijke Philips N V, Medtronic Plc, Allscripts Healthcare Solutions, Inc., Hill-Rom Holdings Inc, International Business Machines Corporation (IBM), Bayer AG, Pfizer Inc., Siemens Healthineers AG, iPatientCare, Inc., Boston Scientific Corporation, and Novartis AG are some of the major companies in the patient-centric healthcare app market.

What are some of the challenges to the growth of the patient-centric healthcare apps market?

Data privacy and security, integrating with existing healthcare IT systems, and addressing the needs of a diverse patient population are some of the key challenges to the patient-centric healthcare apps market.

What are the emerging trends in the patient-centric healthcare app market?

Some of the emerging trends in the patient-centric healthcare app market include the use of wearable technology and remote monitoring, the adoption of virtual care and telehealth, and the growing importance of patient-generated health data.

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1800

Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM

Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!

REACH OUT TO US

Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: [email protected]

Click for Request Sample